Pharmaceutical Industry Adopting QbD for Analytical Testing
This article was originally published in The Gold Sheet
Executive Summary
Both the pharmaceutical industry and regulators are exploring new QbD approaches for analytical method development. FDA regulators have approved analytical QbD submissions and say that regulatory relief will be granted to those firms that use this approach, while the EU has been less accepting.